Ovamit (Clomiphene): How It Induces Ovulation
Mechanism of Action
Ovamit (clomiphene citrate) is a selective estrogen receptor modulator (SERM). It binds to estrogen receptors in the hypothalamus, blocking negative feedback from circulating estrogen. This tricks the brain into perceiving low estrogen levels, prompting increased secretion of gonadotropin‑releasing hormone (GnRH), which stimulates the pituitary to release more follicle‑stimulating hormone (FSH) and luteinizing hormone (LH). The resulting follicular growth leads to ovulation.
Clinical Use
- First‑line treatment for anovulatory infertility (e.g., PCOS).
- Typical regimen: 50 mg daily for 5 days starting on cycle day 3–5.
- Ovulation occurs in ~80% of women; pregnancy rates ~30–40% per cycle.
Monitoring and Side Effects
Ultrasound monitoring minimizes risk of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies. Common side effects: hot flashes, mood swings, bloating, visual disturbances.
Infertility - Related Articles
- Pregnancy 20 Days After Ovulation: Is It Possible?
- Pregnancy After Endometrial Ablation (Novasure) and Tubal Ligation: Extremely Low Probability
- Fertility Drugs: Boosting Your Chances of Conception | [Your Brand/Site Name]
- Baby Gender Prediction: What Science Says About Sex Selection
- Multiple Embryos & Miscarriage: Understanding the Risks
- Infantile Uterus: Hypoplastic Uterus Management and Fertility Options
- Blood Type and Marriage: Can a B Positive Man Marry a Girl?
